AnodyneWiki

Dextroamphetamine

Dextroamphetamine
Dextroamphetamine
Salts
[]
Dextroamphetamine phosphate
Dextroamphetamine phosphate
Dextroamphetamine hemisaccharate
Dextroamphetamine hemisaccharate
Dextroamphetamine hemisulfate
Dextroamphetamine hemisulfate
Dextroamphetamine adipate
Dextroamphetamine adipate
Dextroamphetamine hydrochloride
Dextroamphetamine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass135.21 g/mol [1]
AppearanceColorless liquid [1]
Density0.949 g/cu cm at 15 °C [1]
Melting point-98 [1]
Boiling point64.7 [1]
DecompositionWhen heated to decomposition it emits toxic nitroxides. [1]
SolubilityModerately Soluble [1]
Predicted LogP1.8 [1]
Structural Identifiers
[]
Molecular formulaC9H13N
IUPAC name(2S)-1-phenylpropan-2-amine
SMILESC[C@@H](CC1=CC=CC=C1)N
InChIInChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1
InChIKeyKWTSXDURSIMDCE-QMMMGPOBSA-N
CAS number51-64-9
UNIITZ47U051FI
PubChem CID5826
Pharmacokinetics[]
OnsetImmediate release dosing: 30–45 minutes[3]
Elimination half-life9–11 hours, pH-dependent: 7–34 hours[4]
Duration of actionImmediate release dosing: 3–6 hours, Extended release dosing: 8–12 hours[5][6]
MetabolismCYP2D6, DBH, FMO3[7]
ExcretionKidney (45%); urinary pH-dependent[8]
Routes of administrationBy mouth, transdermal, intravenous, insufflation, rectal
Dependence liabilityPhysical: None, Psychological: Moderate
Addiction liabilityModerate
Toxicity
[]
Mouse:
- oral: 40 mg/kg
Rat:
- oral: 96.8 mg/kg
- oral: 38 mg/kg
- sc: 200 mg/kg
- oral: 96.8 mg/kg
 [1]
Dosing[]
Insufflated
[]
Light≤ 7.1 mg(2x - 50.0%)
Common7.1 - 10 mg
Strong10 - 15 mg(2x - 50.0%)
Heavy15 mg
Extreme15 mg +
Sublingual
[]
Light≤ 3.3 mg(20x - 41.7%)
Common3.3 - 5 mg(26x - 54.2%)
Strong5 mg
Heavy5 mg
Extreme5 mg +(2x - 4.2%)
Oral
[]
Light≤ 5 mg(156x - 49.7%)
Common5 - 10 mg(136x - 43.3%)
Strong10 mg
Heavy10 mg
Extreme10 mg +(22x - 7.0%)
Intrarectal
[]
Light≤ 30.9 mg(2x - 66.7%)
Common30.9 mg
Strong30 - 40 mg
Heavy40 - 46 mg
Extreme46 mg +(1x - 33.3%)
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki)
We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly.

Dextroamphetamine (also known as D-Amphetamine, Dexamphetamine, Dexamfetamine, (S)-Amphetamine, Dexadrine, (+)-Amphetamine, (+)-(S)-Amphetamine, Dexidrine, (S)-(+)-Amphetamine or (S)-1-Phenyl-2-aminopropane) is a stimulant substance of the amphetamine class.

Chemistry

Salts []

Dextroamphetamine is typically found in the form of its phosphate, hemisaccharate, hemisulfate, adipate and hydrochloride salts.

 []

Dextroamphetamine is a single defined stereoisomer (optical activity ( + )).

Dextroamphetamine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The exact mechanism of amphetamines as a class is not known. Dextroamphetamine acts by preventing reuptake, increasing release, and stimulating reverse-transport of dopamine in synaptic clefts in the striatum. Newer evidence shows amphetamines may also alter the number of dopamine transporters in synaptic clefts. [1]

Prodrugs of dextroamphetamine: Benzphetamine, Clobenzorex, Lisdexamphetamine, N-(L-Lysinamidyl)-3,4-methylenedioxyamphetamine.

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction6 (1 contraindicated)
shared target2
shared target1

Subjective effects []

0xea / Dextroamphetamine []
Routes:
  • Oral (2.5 - 20mg)
  • Intravenous (5mg)
Classes:Forms:
  • Sulfate
Source:
  • Dexamfetamine Sulfate 5mg tablets: Tentin
Indication:Effects:
bonzi / Dextroamphetamine []
Routes:
  • Oral (2.5 - 30mg)

 []

  • Australia: Dextroamphetamine is a Schedule 8.[9][10]
  • Brazil: Dextroamphetamine is a A3.[11]
  • Canada: Dextroamphetamine is Prescription only / Schedule G (CDSA I).[12]
  • Germany: Dextroamphetamine is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
  • United Kingdom: Dextroamphetamine is a Class B under the "Misuse of Drugs Act 1971".
  • United States: Dextroamphetamine is a Schedule II under the "Controlled Substances Act".[13][14]
  • European Union: Dextroamphetamine is Prescription only.[15]
  • United Nations: Dextroamphetamine is a Schedule II psychotropic under the "Convention on Psychotropic Substances 1971".
  • Other: Dextroamphetamine is a SE: Förteckning II.[16]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5826, Dextroamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5826
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dextroamphetamine. UNII: TZ47U051FI. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/TZ47U051FI
  3. Green-Hernandez C, Singleton JK, Aronzon DZ. Primary Care Pediatrics. Lippincott Williams & Wilkins. 1 January 2001. https://books.google.com/books?id=o43u_qWT4asC
  4. Adderall- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablet. DailyMed. 27 February 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f22635fe-821d-4cde-aa12-419f8b53db81
  5. Mignot EJ. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. October 2012; 9(4):739–752. PMID 23065655. https://doi.org/10.1007/s13311-012-0150-9
  6. Stahl SM. Prescriber's Guide: Stahl's Essential Psychopharmacology. Cambridge University Press. March 2017.
  7. Lemke TL, Williams DA, Roche VF, Zito W. Foye's Principles of Medicinal Chemistry. Wolters Kluwer Health/Lippincott Williams & Wilkins. 2013.
  8. dextrostat (dextroamphetamine sulfate) tablet [Shire US Inc.]. DailyMed. August 2006. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=1645
  9. Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022. Australian Government Federal Register of Legislation. 26 September 2022. https://www.legislation.gov.au/Series/F2022L01257
  10. Fuller K. ADHD Stimulant Prescribing Regulations & Authorities in Australia & New Zealand. AADPA. 20 February 2022. https://aadpa.com.au/adhd-stimulant-prescribing-regulations-in-australia-new-zealand/
  11. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  12. Product monograph brand safety updates. Health Canada. 6 June 2024. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html
  13. Dexedrine spansule- dextroamphetamine sulfate capsule, extended release. DailyMed. 10 January 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc717b9b-22ea-4c60-a1d4-ee38a40bce78
  14. Xelstrym- dextroamphetamine patch, extended release. DailyMed. 6 January 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0862f02a-72a8-41cc-8845-57cf4974bb6f
  15. List of nationally authorised medicinal products : Active substance(s): dexamfetamine : Procedure No. PSUSA/00000986/202109. Ema.europa.eu. https://www.ema.europa.eu/documents/psusa/dexamfetamine-list-nationally-authorised-medicinal-products-psusa/00000986/202109_en.pdf
  16. Attentin, Tablett 5 mg. FASS. 24 April 2026. https://fass.se/health/product/20110721000068/fass-text

Data sources []

SourceStatusUpdated (UTC)
dosingok2026-11-20 04:08:29
drugspromissing (no DrugsPRO reagent data)2026-11-20 04:08:25
erowidmissing (no Erowid substance of that name)2026-11-20 04:08:25
gsrsok2026-11-20 04:08:29
hmdbmissing (hmdb.ca refused automated access to HMDB0015516)2026-11-20 04:08:25
keggok2026-11-20 04:08:26
pubchemok2026-11-20 04:08:25
redditmissing (no r/tripreports posts mention it)2026-11-20 04:08:25
sidermissing (not in SIDER)2026-11-20 04:08:25
structureok2026-11-20 04:08:25
wikipediaok2026-11-20 04:08:25